Relief of symptoms associated with allergic rhinitis eg, sneezing, nasal discharge and itching, as well as ocular itching and burning. Relief of signs and symptoms of chronic urticaria and other allergic dermatologic disorders.
Adult & children ≥12 year: 1 tab once daily. Children 6-12 year, >30 kg: 1 tab once daily, ≤30 kg: ½ tab once daily.
Patients who have shown hypersensitivity or idiosyncrasy to the components of Ardin.
Use in pregnancy & lactation: Safe use of Ardin producs during pregnancy has not been established; therefore, use only if potential benefit justifies potential risk to fetus. Since loratadine is excreted in breast milk, a decision should be made whether to discontinue nursing or discontinue Ardin.
Use in children: Safety and efficacy of Ardin in children <6 years have not been established.
Safe use of Ardin producs during pregnancy has not been established; therefore, use only if potential benefit justifies potential risk to fetus. Since loratadine is excreted in breast milk, a decision should be made whether to discontinue nursing or discontinue Ardin.
In controlled pediatric clinical trials, the incidence of treatment-related fatigue, sedation, thirst, which were rarely reported, is not clinically significant.
Ardin should be discontinued approximately 48 hrs prior to skin testing procedures since antihistamines may prevent or diminish otherwise positive reactions to dermal reactivity indicators.
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic use.
Ardin tab 10 mg
50 × 10's
Sign Out
